⌘K

Login Start Free

Home/Filings/4/0001209191-06-003183

4//SEC Filing

STRAUSS ROBERT C 4

Accession 0001209191-06-003183

CIK 0000815838other

View on SEC.gov Company Profile

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 12:08 PM ET

Size

7.4 KB

Accession

0001209191-06-003183

Insider Transaction Report

Form 4

Period: 2006-01-10

NOVEN PHARMACEUTICALS INCNOVN

STRAUSS ROBERT C

DirectorPresident, CEO & Chairman

Transactions

Exercise/Conversion
Common Stock ($ .0001 par value)
2006-01-10$5.63/sh+40,000$225,000→ 171,349 total
Exercise/Conversion
Stock Option (Right to Buy)
2006-01-10−40,000→ 0 total
Exercise: $5.63Exp: 2006-01-11→ Common Stock ($ .0001 par value) (40,000 underlying)

Footnotes (1)

[F1]10% exercisable after 1/12/2000; 20% exercisable after 1/12/2001; 20% exercisable after 1/12/2002; 25% exercisable after 1/12/2003; 25% exercisable after 1/12/2004.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

NOVEN PHARMACEUTICALS INC

CIK 0000815838

Entity typeother

Related Parties

1

filerCIK 0001224100

Filing Metadata

Form type: 4
Filed: Jan 11, 7:00 PM ET
Accepted: Jan 12, 12:08 PM ET
Size: 7.4 KB

View on SEC.gov